MSOS News

Post date: 2 years 1 month ago

One of the leading voices in medication safety, ISMP Vice President Judy Smetzer, BSN, RN, has announced that she will be retiring at the end of February. Judy will continue to work with ISMP as a contractor for several months to help transition responsibilities. She will be incredibly missed—please join us in wishing her well. For details: https://www.ismp.org/node/29911

Post date: 2 years 1 month ago

Nurse colleagues: an evidence-based checklist for IV push best practices is now available! The checklist is based on ISMP guidelines and INS standards, and can be used as a teaching tool to help standardize practice and assess competency: https://qsen.org/iv-push-evidence-based-practice-checklist/

Post date: 2 years 2 months ago

Thank you again to the many hospitals and ambulatory facilities that have already submitted their findings for the ISMP Medication Safety Self Assessment®️ for Perioperative Settings! We know that this has been a particularly challenging time for healthcare practitioners continuing to deal with COVID-19 and many other resource-intensive issues.

If your facility has not yet submitted its findings and would still like to participate in this valuable endeavor, there are only 2 more weeks left! Be sure to submit by the February 11 deadline in order to receive your facility’s weighted scores and to gain access to national aggregate results which can be used to compare your facility to demographically similar organizations. This will be the final submission deadline; ISMP is not able to offer any additional deadline extensions.

Post date: 2 years 2 months ago

Sign up now for the next MSOS Member Briefing webinar scheduled to be held on Thursday, January 27, 2022 from 1:00-2:00 PM ET.

Register Now: https://ecri.zoom.us/webinar/register/WN_yXOM9MJGTCuZj_XasIjAAg

Short medication safety-related presentations for this webinar will include:

• Safeguards Around Adult Use of Continuously Inhaled Epoprostenol
Sammy Burton, PharmD, FISMP
Cleveland Clinic

• Utilizing the EMR to Assure Safe Paralytic Infusion Practices
Mara Weber, PharmD
OhioHealth

• Multi-Chamber Bag Parenteral Nutrition
Andrew Mays, PharmD
ASPEN PN Safety Committee

• ISMP Update
Michael R. Cohen, RPh, MS, ScD (hon.), DPS (hon.), FASHP, President, Institute for Safe Medication Practices

Post date: 2 years 2 months ago

ISMP has identified possible safety issues with Paxlovid, which was recently authorized for the treatment of COVID-19. Tablets need to be removed from the blister pack for patients with moderate renal impairment. For a copy of ISMP’s special alert with safe practice recommendations, visit: https://www.ismp.org/node/29033

Pages